Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2019, vol. 28, nr 3, March, p. 307–312

doi: 10.17219/acem/76130

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Do CTRC mutations affect the development of alcoholic chronic pancreatitis and its course among Poles: Preliminary study

Halina Cichoż-Lach1,A,B,C,D, Małgorzata Michalak-Wojnowska2,A,B,C, Emilia Lis-Janczarek1,B,C,D, Jacek Wojcierowski3,E,F, Marcin Hydzik3,B,C

1 Department of Gastroenterology, Medical University of Lublin, Poland

2 Department of Cancer Genetics, Medical University of Lublin, Poland

3 Genetic Testing Laboratory, Lublin, Poland


Background. Genetic mutations are one of the etiological factors that predispose people to develop chronic pancreatitis.
Objectives. The aim of our study was to examine the effect of p.Trp55*, p.Arg254Trp and c.738_761del mutations in the chemotrypsin gene (CTRC) on the development of alcoholic chronic pancreatitis (ACP) in order to answer the questions whether these mutations vary between gender groups, whether they were related to the age when ACP was first diagnosed, and whether they affected the morphological changes in the pancreas and the course of ACP.
Material and Methods. The study included 124 patients with ACP, 52 with nonalcoholic pancreatitis and 52 controls. The p.Trp55*, c.738_761del and p.Arg254Trp mutations in the CTRC gene were tested by the polymerase chain reaction (PCR).
Results. The c.738_761del and p.Arg254Trp mutations occurred in 3.07% and 1.31% of cases, respectively. None of the examined patients were found to have the p.Trp55* mutation. The frequency of detected mutations did not significantly differ between the study groups. The c.738_761del mutation was detected more frequently in women than in men. No significant differences were found in the age at ACP onset, morphological changes affecting the pancreas, or in the course of ACP between the patients with and without the 2 examined mutations. The c.738_761del mutation was significantly more frequent in the diabetic patients than in the non-diabetics. The patients with this mutation more frequently required surgery than those without the c.738_761del mutation.
Conclusion. No relationship between the c.738_761del and p.Arg254Trp mutations and the development of APC was found. The c.738_761del mutation was more frequent in females than in males. Neither mutation affected the patient’s age at ACP onset or its course. In contrast to p.Arg254Trp, the c.738_761del mutation correlated with diabetes development and the need for surgery in the course of ACP.

Key words

alcohol, alcoholic chronic pancreatitis, CTRC mutations

References (19)

  1. LaRusch J, Lozano-Leon A, Stello K, et al. for the NAPS2 Consortium. The common chymotrypsinogen C (CTRC) variant G60G (C.180T) increases risk of chronic pancreatitis but not recurrent acute pancreatitis in a North American population. Clin Transl Gastroenterol. 2015;6(1):e68. doi: 10.1038/ctg.2014.13
  2. Whitcomb DC, Yadav D, Adam S, et al. Multicenter approach to recurrent acute and chronic pancreatitis in the United States: The North American Pancreatitis Study 2 (NAPS2). Pancreatology. 2008;8:520–531.
  3. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144:1252–1261.
  4. Yadaw D, Whitcomg DC. The role of alcohol and smoking in pancreatitis. Nature Rev Gastroenterol Hepatol. 2010;7:131–145.
  5. Mądro A, Ciesielka M, Celiński K, et al. The genetic predisposition and its impact on the diabetes mellitus development in patients with alcoholic chronic pancreatitis. Gastroenterol Res Pract. 2015;2015:309156.
  6. Global Status Report on Alcohol and Health 2011. Accessed September 11, 2012.
  7. Ravi Kanth VV, Reddy DN. Genetics of acute and chronic pancreatitis: An update. World J Gastrointest Pathophysiol. 2014;5:427–437.
  8. Howell WM, Pead PJ, Shek FW, et al. Influence of cytokine and ICAM-1 gene polymorphisms on susceptibility to chronic pancreatitis. J Clin Pathol. 2005;58:595–599.
  9. Shelton CA, Whitcomb DC. Genetics and treatments options for recurrent acute and chronic pancreatitis. Curr Treat Options Gastroenterol. 2014;12:359–371.
  10. Masamune A. Genetics of pancreatitis: The 2014 update. Tohoku J Exp Med. 2014;232:69–77.
  11. Cichoż-Lach H, Michalak M, Lis E, et al. The N34S mutation of the SPINK1 gene and alcoholic chronic pancreatitis. Pol Arch Med Wewn. 2012;122:277–283.
  12. Szmola R, Sahin-Tóth M. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: Identity with Rinderknecht’s enzyme Y. Proc Natl Acad Sci USA. 2007;104:11227–11232.
  13. Rosendahl J, Witt H, Szmola R, et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet. 2008;40:78–82.
  14. Felderbauer P, Karakas E, Fendrich V, Lebert R, Bartsch DK, Bulut K. Multifactorial genesis of pancreatitis in primary hyperparathyroidism: Evidence for “protective” (PRSS2) and “destructive” (CTRC) genetic factors. Exp Clin Endocrinol Diabetes. 2011;119:26–29.
  15. Masson E, Chen JM, Scotet V, Le Marechal C, Ferec C. Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis. Hum Genet. 2008;123:83–91.
  16. Zhou J, Sahin-Tóth M. Chymotrypsin C mutations in chronic pancreatitis. J Gastroenterol Hepatol. 2011;26:1238–1246.
  17. Derikx MH, Drenth JP. Genetic factors in chronic panreatitis; implications for diagnosis, management and prognosis. Best Pract Res Clin Gastroenterol. 2010;24:251–270.
  18. Reddy DN, Prasad SS. Genetic basis of chronic pancreatitis in Asia Pacific region. J Gastroenterol Hepatol. 2011;26(Suppl 2):2–5.
  19. Szmola R, Bence M, Carpentieri A, et al. Chymotrypsin C is a co-activator of human pancreatic procarboxypeptidases A1 and A2. J Biol Chem. 2011;286:1819–1827.